Nephron sparing surgery for unilateral non-syndromic wilms tumor. 2014

R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
KLES Kidney Foundation, KLES Dr Prabhakar Kore Hospital & MRC, Belgaum, Karnataka India ; Department of Urology, KLE University's JN Medical College, Belgaum, 590010 India.

The initial therapy for most children with Wilms tumor is radical nephrectomy. Several centers, have explored the role of Nephron-sparing procedures in children with unilateral non-syndromic Wilms tumors. The primary motivation for this approach is concern about late occurrence of renal dysfunction after unilateral nephrectomy. We report our experience with NSS for unilateral non-syndromic Wilms tumor. We reviewed the records of nine children who underwent nephron sparing surgery for unilateral, nonsyndromic Wilms tumors at our Hospital between Jan 2000 through Jan 2012. All patients received preoperative chemotherapy with two drugs (vincristine, and dactinomycin) following which patients underwent tumor resection. Subsequent renal function was assessed by estimating the glomerular filtration rate using creatinine clearance and other measures of long-term renal function assessment included blood pressure evaluation and the need for antihypertensive medications. During the study period nine children with a mean age 19.66 ± 14.37 months at diagnosis and presenting with unilateral non-syndromic Wilms tumor underwent nephron sparing surgery. In all the nine children, the renal plane of resection showed a tumor-free margin. Post-operative serum creatinine repeated at the end of 3 months revealed maintenance of good renal function in all children. Nephron sparing surgery is a safe and effective option in the management of early stage unilateral non-syndromic Wilms tumor. It is oncologically safe and does not lead to decreased local tumor control. The function of the kidney remnant remains rather well.

UI MeSH Term Description Entries

Related Publications

R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
April 2024, Pediatric nephrology (Berlin, Germany),
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
March 1997, Medical and pediatric oncology,
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
June 2018, Urology,
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
July 2012, Journal of pediatric surgery,
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
January 2023, Frontiers in pediatrics,
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
March 2015, Pediatric surgery international,
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
July 2017, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
January 2020, Journal of pediatric surgery,
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
December 2014, Pediatric blood & cancer,
R B Nerli, and V C Pujar, and M B Hiremath, and S M Jali, and S S Joshi, and S C Hiremath, and A K Guntaka
January 2016, Urologic oncology,
Copied contents to your clipboard!